Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer’s disease
- 8 June 2023
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 26 (7) , 1196-1207
Abstract
Microglia play a critical role in brain homeostasis and disease progression. In neurodegenerative conditions, microglia acquire the neurodegenerative phenotype (MGnD), whose function is poorly understood. MicroRNA-155 (miR-155), enriched in immune cells, critically regulates MGnD. However, its role in Alzheimer’s disease (AD) pathogenesis remains unclear. Here, we report that microglial deletion of miR-155 induces a pre-MGnD activation state via interferon-γ (IFN-γ) signaling, and blocking IFN-γ signaling attenuates MGnD induction and microglial phagocytosis. Single-cell RNA-sequencing analysis of microglia from an AD mouse model identifies Stat1 and Clec2d as pre-MGnD markers. This phenotypic transition enhances amyloid plaque compaction, reduces dystrophic neurites, attenuates plaque-associated synaptic degradation and improves cognition. Our study demonstrates a miR-155-mediated regulatory mechanism of MGnD and the beneficial role of IFN-γ-responsive pre-MGnD in restricting neurodegenerative pathology and preserving cognitive function in an AD mouse model, highlighting miR-155 and IFN-γ as potential therapeutic targets for AD.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG054672, R01AG051812, R01AG075509, R21AG076982, R41AG073059, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R41AG073059, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, R01AG054672, RF1AG054199, R01AG066429, R01AG072719, R01AG067763, R41AG073059, R01AG075509)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS088137)
- U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY027921, K12 EY016335, K08 EY030160, K12 EY016335, K08 EY030160)
- BrightFocus Foundation (2020A016806)
- Cure Alzheimer’s Fund (APOE consortium, APOE consortium)
- U.S. Department of Health & Human Services | National Institutes of Health (F31AG071106, T32GM008541)
- Research to Prevent Blindness Career Development Award.
This publication has 67 references indexed in Scilit:
- Alteration of the microRNA network during the progression of Alzheimer's diseaseEMBO Molecular Medicine, 2013
- Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent MannerNeuron, 2012
- MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβCellular & Molecular Immunology, 2009
- miR-155 gene: A typical multifunctional microRNABiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s DiseaseScience, 2009
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- MicroRNA-155 is induced during the macrophage inflammatory responseProceedings of the National Academy of Sciences, 2007
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003